Trial search - ClinicalTrials.eu

Opportunities for Healthy Volunteers

Contribute to medical research by participating in studies designed for healthy participants in your selected area.

↓

Matched clinical trials

Study of NGM707 and Pembrolizumab for Patients with Advanced or Metastatic Solid Tumors

Not recruiting

2 1 1
Investigated Diseases:
- Neoplasm
Investigated Drugs:
- Ngm707
- Pembrolizumab
Study of BMS-986442 and Nivolumab, Alone or with Chemotherapy, for Patients with Advanced Solid Tumors and Non-Small Cell Lung Cancer

Not recruiting

2 1 1 1
Investigated Diseases:
- Neoplasm
- Non-small cell lung cancer
Investigated Drugs:
Study of Olaparib and Pembrolizumab for Patients with Advanced Cancer with HRRm or HRD Mutations

Not recruiting

2 1 1 1
Investigated Diseases:
- Neoplasm
Investigated Drugs:
- Olaparib
- Pembrolizumab
+2
Study on the Safety and Tolerability of Olaparib in Children and Adolescents with Solid Tumors

Not recruiting

1 1 1 1
Investigated Diseases:
- Neoplasm
Investigated Drugs:
- Olaparib
Study of MCLA-129 with Chemotherapy and Osimertinib for Patients with Advanced Non-Small Cell Lung Cancer and Other Solid Tumors

Not recruiting

1 1 1 1
Investigated Diseases:
- Neoplasm
Investigated Drugs:
Study on the Safety of Avelumab for Patients with Solid Tumors Continuing Treatment

Not recruiting

3 1 1 1
Investigated Diseases:
- Neoplasm
Investigated Drugs:
- Avelumab
+1
Long-term study of dabrafenib and trametinib in children and adolescents with cancers that have V600 mutation

Not recruiting

3 1 1 1
Investigated Diseases:
- Neoplasm
Investigated Drugs:
+4
Study of Olaparib for Patients with Advanced Cancer Having HRRm or HRD Mutations

Not recruiting

2 1 1
Investigated Diseases:
- Neoplasm
Investigated Drugs:
- Olaparib

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes